Skip to content
 
REPORT

Revolutionizing pharmaceutical R&D:
Harnessing AI to combat escalating costs

In the pharmaceutical sector, R&D teams are constantly working to innovate while maximizing the value of their time and resources. The life-saving potential of new drugs and treatments is undeniable, but pharmaceutical companies face increasing costs and longer development cycle times. Every stage of R&D has experienced rising costs, from discovery through clinical trials to the market.

Fortunately, change is already in motion at leading pharma companies. AI and other disruptive technologies are helping R&D teams streamline and automate drug discovery efforts — and slash costs in the process. 

In this report we explore how pharma companies are leveraging the power of AI to combat escalating costs in R&D.

Download the report to take a deeper dive into:

  • The research cost conundrum and why it exists.
  • How AI is offsetting drug development costs.
  • The financial benefits of an AI-powered expertise directory in drug discovery.

Plus: Learn how Roche and Merck are using secure AI to transform how they work while reducing costs and fostering innovation.

Download the report today!

Ready to set the knowledge of your enterprise free?
Get it in touch with a Starmind representative.